Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Penumbra, Inc. Common Stock (NY: PEN )

267.13 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 775
Open 267.13
Bid (Size) 106.86 (2)
Ask (Size) 424.89 (1)
Prev. Close 267.13
Today's Range 267.13 - 267.13
52wk Range 148.00 - 310.00
Shares Outstanding 36,580,540
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
3 Mid-Cap Stocks in Hot Water
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory

Performance

YTD
+11.31%
+11.31%
1 Month
+2.33%
+2.33%
3 Month
+5.31%
+5.31%
6 Month
+32.04%
+32.04%
1 Year
+11.65%
+11.65%

More News

Read More
Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For
Via StockStory
Artivion (AORT) Q4 Earnings: What To Expect
Via StockStory
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook
Via Benzinga
Topics Earnings
Exposures Financial
10 Analysts Assess Penumbra: What You Need To Know
Via Benzinga
Peering Into Penumbra's Recent Short Interest
Via Benzinga
(PEN) - Analyzing Penumbra's Short Interest
Via Benzinga
Why Penumbra (PEN) Stock Is Trading Up Today
Via StockStory
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Profit Machine Penumbra Surges On Solid Fourth-Quarter Beat, But Guidance Lags
Via Investor's Business Daily
Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates
Via StockStory
Topics Earnings
Exposures Financial
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Via StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
Via StockStory
Earnings Scheduled For February 18, 2025
Via Benzinga
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
Via StockStory
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Inspire Medical's Sleep Innovations Driving Big Gains
Via Investor's Business Daily
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Inari Medical Catapults 30% On Rumored Stryker Takeover
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Via Benzinga
This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.